High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2018
Source ID
10.1016/j.eplepsyres.2018.09.016

Entities

People

  • Benoit Scherrer
  • Bridget Kent
  • Darcy A Krueger
  • Deborah Pearson
  • Donna S. Murray
  • E. Martina Bebin
  • Ellen Hanson
  • Ernst Schmid
  • Gary R. Cutter
  • Hope Northrup
  • Joyce Y. Wu
  • Jurriaan M Peters
  • Kira Dies
  • Marian E. Williams
  • Monisha Goyal
  • Mustafa Şahin
  • Nicole Bing
  • Rajna Filip-dhima
  • Sarah O’kelley
  • Shaun A. Hussain
  • Stephanie Bruns
  • Steven L. Roberds

Organizations

  • Congressionally Directed Medical Research Programs
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • GW Pharmaceuticals
  • Hoffmann-La Roche
  • Lundbeck
  • Milken Family Foundation
  • National Center for Advancing Translational Sciences
  • National Institute of Mental Health
  • National Institutes of Health
  • Novartis
  • Pfizer
  • United States Department of Defense
  • University of California, Berkeley